跳至主要内容
临床试验/NCT01883596
NCT01883596Unknown4 期

Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in a Pediatric Intensive Care Unit.

Sinaloa Pediatric Hospital1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
70
试验地点
1
主要终点
Incidence of ventilator associated pneumonia

研究概览

简要总结

To determine the efficacy of prophylaxis with 0.12% chlorhexidine gluconate compared with placebo to prevent ventilator associated pneumonia in children admitted to a pediatric critical care unit.

详细描述

Randomised controlled trial to determine the efficacy of 0.12% chlorhexidine gluconate compared with placebo to prevent ventilator associated pneumonia in children admitted to a pediatric critical care unit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
1 Month 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children aged 1 month to 18 years admitted to the intensive care unit.
  • Intubated for more than 48 hours.

排除标准

  • Clinical or radiological diagnosis of pneumonia previous to the endotracheal intubation.
  • Allergy to chlorhexidine.
  • Known immune deficiency.
  • Elimination Criteria:
  • Transfer to another hospital.

研究组 & 干预措施

0.12% Chlorhexidine

Experimental

Bexident® (0.12% chlorhexidine) solution, applied topically, every 8 hrs.

干预措施: 0.12% chlorhexidine solution (Drug)

Placebo

Placebo Comparator

7.4% alcohol, glycerine, normal saline solution, applied topically, every 8 hrs.

干预措施: Placebo (Drug)

结局指标

主要结局

Incidence of ventilator associated pneumonia

时间窗: Participants will be followed for the duration of intensive care unit stay, an expected average of 2 weeks

次要结局

  • Mortality(Participants will be followed for the duration of intensive care unit stay, an expected average of 2 weeks)
  • Days of mechanical ventilation(From date of randomization until the date of death or date of extubation, whichever comes first, an expected average of 2 weeks)
  • Length of stay(From date of randomization until the date of death or date of discharge from the intensive care unit, an expected average of 2 weeks)

研究者

发起方
Sinaloa Pediatric Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jesús Javier Martínez-García

MD

Sinaloa Pediatric Hospital

研究点 (1)

Loading locations...

相似试验